维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

16篇 您的检索式：作者名="Nakov R"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Incidence and clinical relevance of heparin induced antibodies in patients with deep vein thrombosis treated with unfractionated or low-molec ular-weight helSarin显示文摘	Lindhoff LE Nakov R Misselwitx F	2002	Br J Hoemated2002，118，4：	1
	2	Incidence and clinical relevance of heparin induced antibodies in patients with deep vein thrombosis treated with unfractionated or low- molecular weight heparin 显示文摘	Lindhoff- Last E Nakov R Misselwitz F	2002	Br J Haematol2002，118，4：	1
	3	Darsentan:an effective endothelin A receptor antagonist for treatment of hypertension显示文摘	Nakov R Pfarr E Eberle S	2002	Am J Hypertens2002，15，：	1
	4	Effects of a low molecular weight heparin on thrombus regression and recurrent thromboembolism in patients with deep vein thrombosis 显示文摘	Breddin HK Hach- Wunderle V Nakov R etal	2001	N Engl J Med2001，344，9：	1
	5	Antihypertensive therapy with verapamil SR plus trandolapfil versus atenolol plus chlorthalidone on glycemic control显示文摘	Holzgreve H Nakov R Beck K	2003	Am J Hypertens2003，16，：	1
	6	Classification of semantic relations between nominals显示文摘	Girju R Nakov P Nastase V	2009	Language Resources and Evaluation2009，43，2：	1
	7	Incidence and clinical relevance of heparin - induced antibodies in patients with deep vein thrombosis treated with unfmctionated or low - molecular -weight hcparin 显示文摘	Lindhoff - Last E Nakov R Misselwitz F	2002	Br J Haematol2002，118，4：	1
	8	Effects of a low - molecular - weight heparin on thrembus regression and recurrent thromboembolism in patients with deep vein thrembosis显示文摘	Breddin HK Hach- Wunderle V Nakov R	2001	N Engl J Med2001，344，9：	1
	9	Darusentan: an effective endothelinA receptor antagonist for treatment of hypertension 显示文摘	Nakov R Pfarr E Eberle S	2002	Am J Hyper- tens2002，15，7：	1
	10	Darusentan: an ef- fective endothelin A receptor antagonist for treatment of hypertension显示文摘	Nakov R Pfarr E Eberle S	2002	American Journal of Hyperten- sion2002，15，7：	1
	11	Incidence and clinical relevance of heparin-induced antibodies in patients with deep vein thrombosis treated with unfractionated or low-molecular-weight heparin显示文摘	Lindhoff Last E Nakov R Misselwitz F	2002	Br J Haematol2002，118，4：	1
	12	Classification of semantic relations between nominals显示文摘	Girju R Nakov P Nastase V	2009	Language Resources and Evaluation2009，43，2：	1
	13	Darusentan; an effectiveendothelinA receptor antagonist for treatment of hypertension显示文摘	NAKOV R PFARR E EBERLE S	2002	Am J Hypertens2002，15，71：	1
	14	Effects of a low- molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis显示文摘	Breddin HK Hach-Wunderle V Nakov R	2001	N Engl J Med2001，344，9：	1
	15	Chemometricapproach for optimization of HILIC method forsimultaneous determination of imipenem and cilastatinsodium in powder for injection 显示文摘	Nakov N Petkovska R Acevska J	2014	J Liq ChromatogrRelat TechnoU2014，37，：	1
	16	Use of the low-molecular-weight heparin reviparin to prevent deep-vein thrombosis after leg injury requiring immobilization 显示文摘	Lassen M R Borris L C Nakov R L	2002	N Engl J Med2002，347，10：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费